COPD increases mortality risk in hospitalized COVID-19 patients: CHEST
USA: The presence of COPD in hospitalized COVID-19 patients may lead to a higher risk of mortality, suggests a recent study in the journal CHEST. Further, COPD prevalence in these patients was found to be even lower than the general population, this may be due to higher precautionary measures taken by COPD patients for coronavirus.
The findings of the study were presented at the American College of Chest Physicians (CHEST) 2020 Annual Meeting held from October 18-21, 2020.
The current COVID-19, which continues to spread worldwide, is caused by severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) infection. Some of the published studies have raised concerns on the association between COPD (chronic obstructive pulmonary disease) and worse clinical outcomes in COVID-19. The aim of this study by Gerard Kiernan and Vikramaditya Samala Venkata from Dartmouth-Hitchcock Medical Center, Lebanon, United States, was to determine the association between baseline COPD and clinical outcomes in COVID-19 patients.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.